Braizon Therapeutics, Inc. is a bio-venture firm originating from the University of Tokyo and Tokyo Medical and Dental University.
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: Tokyo
State: Tokyo
Zip:
Country: Japan
Braizon Therapeutics, Inc. was established with the aim of applying and implementing, within the fields of medicine and life science, innovative technology for the delivery of drugs to the brain as the outcome of collaborative research by Professor Kazunori Kataoka from the Graduate School of Engineering/Medicine, the University of Tokyo and Professor Takanori Yokota from the Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 8/2018 | Series B | 3 | $5.8M |
Fast Track Initiative, Inc. SMBC Venture Capital UTokyo Innovation Platform Fast Track Initiative, Inc. SMBC Venture Capital UTokyo Innovation Platform |
7/2021 | Series B | 1 | $9.5M |
Fast Track Initiative, Inc. Fast Track Initiative, Inc. |
3/2016 | Series A | 1 | - |
Fast Track Initiative, Inc. Fast Track Initiative, Inc. |
3/2016 | Series A | 1 | - |
Fast Track Initiative, Inc. Fast Track Initiative, Inc. |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|